Althea Group Holdings Ltd (ASX: AGH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Althea Group Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$15.40 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
406.50 million
Earnings per share
-0.058
Dividend per share
N/A
Year To Date Return
-47.44%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Althea Group Holdings Ltd (ASX: AGH)
Latest News
Share Gainers
Why cannabis company Althea is pushing higher today
Share Fallers
Why Althea, Australian Pharma, Cleanaway, & Strike Energy sank lower
Share Fallers
Althea share price crushed after Aphria dumps 37 million shares
Share Market News
Why this ASX cannabis share price is in limbo today
Share Market News
The cannabis collapse: ASX marijuana shares going cheap
Share Gainers
Why this ASX cannabis share surged higher today
Share Market News
Buy high, sell low: Canopy Growth Corp dumps Auscann pot stock stake
⏸️ Shares to Watch
What is the best ASX cannabis share to buy for 2020?
Share Gainers
Why this ASX cannabis share jumped 7.5% higher today
Share Gainers
Why Althea, City Chic, CSL, & Kathmandu shares raced higher today
Share Gainers
Why cannabis company Althea surged 10% higher today
Share Fallers
What's next for these 4 beaten-down ASX cannabis stocks?
AGH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Althea Group Holdings Ltd
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, andCorporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into geographic segments: Australia, the United Kingdom, Canada, Germany and Ireland. The company earns key revenue from Australia and through the sale of medicinal cannabis products.
AGH Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 22 Nov 2024 | $0.04 | $0.00 | 0.00% | 178,698 | $0.04 | $0.04 | $0.04 |
| 21 Nov 2024 | $0.04 | $0.00 | 0.00% | 300,056 | $0.04 | $0.04 | $0.04 |
| 20 Nov 2024 | $0.04 | $0.00 | 0.00% | 168,013 | $0.04 | $0.04 | $0.04 |
| 19 Nov 2024 | $0.04 | $0.00 | 0.00% | 2,068,184 | $0.04 | $0.04 | $0.04 |
| 18 Nov 2024 | $0.04 | $0.00 | 0.00% | 331,630 | $0.04 | $0.04 | $0.04 |
| 15 Nov 2024 | $0.04 | $0.00 | 0.00% | 99,627 | $0.04 | $0.04 | $0.04 |
| 14 Nov 2024 | $0.04 | $0.00 | 0.00% | 487,978 | $0.04 | $0.05 | $0.04 |
| 13 Nov 2024 | $0.04 | $0.00 | 0.00% | 1,911,086 | $0.04 | $0.04 | $0.04 |
| 12 Nov 2024 | $0.04 | $0.00 | 0.00% | 203,801 | $0.04 | $0.04 | $0.04 |
| 11 Nov 2024 | $0.05 | $0.00 | 0.00% | 15,426 | $0.05 | $0.05 | $0.04 |
| 08 Nov 2024 | $0.04 | $0.00 | 0.00% | 1,179,786 | $0.05 | $0.05 | $0.04 |
| 07 Nov 2024 | $0.05 | $0.00 | 0.00% | 35,910 | $0.05 | $0.05 | $0.04 |
| 06 Nov 2024 | $0.05 | $0.00 | 0.00% | 1,039,933 | $0.04 | $0.05 | $0.04 |
| 05 Nov 2024 | $0.04 | $0.00 | 0.00% | 5,332 | $0.05 | $0.05 | $0.04 |
| 04 Nov 2024 | $0.04 | $0.00 | 0.00% | 549,298 | $0.05 | $0.05 | $0.04 |
| 01 Nov 2024 | $0.05 | $0.01 | 23.26% | 1,196,892 | $0.05 | $0.05 | $0.04 |
| 31 Oct 2024 | $0.04 | $0.00 | 0.00% | 2,541,719 | $0.04 | $0.05 | $0.04 |
| 30 Oct 2024 | $0.04 | $0.00 | 0.00% | 248,302 | $0.04 | $0.04 | $0.04 |
| 29 Oct 2024 | $0.04 | $0.00 | 0.00% | 698,885 | $0.04 | $0.04 | $0.04 |
| 28 Oct 2024 | $0.04 | $0.00 | 0.00% | 149,414 | $0.04 | $0.04 | $0.04 |
| 25 Oct 2024 | $0.04 | $0.00 | 0.00% | 667,424 | $0.04 | $0.04 | $0.04 |
| 24 Oct 2024 | $0.04 | $0.00 | 0.00% | 2,290,293 | $0.04 | $0.04 | $0.04 |
| 23 Oct 2024 | $0.04 | $0.00 | 0.00% | 590,391 | $0.05 | $0.05 | $0.04 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 01 Nov 2024 | Vaughan Webber | Buy | 1,000,000 | $44,485 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Alan Maclean Boyd | Non-Executive Director | Jun 2018 |
Mr Boyd started his professional career in chartered accounting firms in England and Australia and has broad financial experience across many industry sectors. He is Chair of the Risk and Compliance Management Committee.
|
| Mr Vaughan Webber | Non-Executive ChairmanNon-Executive Director | Aug 2024 |
Mr Webber is a company director and finance executive with over 20 years of experience, His career highlights include Non-Executive Director, HUB24 Ltd (ASX:HUB) (2012-2018), Independent Chairman, Wentworth Holdings Ltd (ASX:WWM) (2009-2013) ,Ltd (ASX:TOP) Independent Chairman, Solvar Ltd (ASX:SVR) (2014-2016), Non-Executive Director, Anchor Resources Ltd (ASX:AHR) (2011-2019). Mr Webber currently holds a number of Board roles including Chairman in the private sector.
|
| Mr Joshua Michael Fegan | Chief Executive OfficerManaging Director | Jun 2018 |
Mr Fegan is the founder of Althea Group Holdings Limited and has experience in business building, sales and marketing. He has a range of business and strategy skills and has previously held a number of senior management roles at national value-based retailer, Strathfield Group.
|
| Penelope Dobson | Non-Executive Director | Nov 2018 |
Ms Dobson is an experienced global healthcare executive. She has worked in the broad life-science space since her training as a pharmacist in New Zealand, including many years in the global pharmaceutical industry. She is a member of the Risk and Compliance Management Committee.
|
| Mr Robert Meissner | Chief Financial OfficerCompany Secretary | Apr 2019 |
-
|
| Robert Meissner | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Adman Lanes Pty Ltd | 60,000,000 | 14.76% |
| Joshua Michael Fegan | 57,444,030 | 14.13% |
| UBS Nominees Pty Ltd | 10,769,451 | 2.65% |
| Citicorp Nominees Pty Limited | 10,558,096 | 2.60% |
| Mancann Pty Ltd | 10,000,000 | 2.46% |
| Hootch Pty Ltd | 7,500,000 | 1.85% |
| Hunt Prosperity Pty Ltd Investius PB Micro Cap A/C> | 7,500,000 | 1.85% |
| Hosanda Corporation Pty Limited | 6,500,000 | 1.60% |
| Mr Thomas Mark Nowak | 5,000,000 | 1.23% |
| HSBC Custody Nominees (Australia) Limited | 4,807,529 | 1.18% |
| Pither Investments Pty Ltd Pither Investments A/C> | 4,800,000 | 1.18% |
| Rizzo Super Pty Ltd Rizzo Super Fund A/C> | 4,500,000 | 1.11% |
| McLennan Trading Pty Ltd | 4,100,000 | 1.01% |
| Kevevans Pty Ltd | 3,850,000 | 0.95% |
| Vidog Capital Pty Ltd | 3,770,834 | 0.93% |
| Mr Orlando Alfredo Guerra Curvelo | 3,500,000 | 0.86% |
| Mrs Nola Kendall Fletcher | 3,250,000 | 0.80% |
| Nintieth Y Pty Ltd I K Cldwell & Co Staff A/C> | 3,000,000 | 0.74% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 2,952,629 | 0.73% |
| Mr Hooi Giap Toh Yang and Toh Family A/C> | 2,500,000 | 0.62% |
